Skip to content
Search

Latest Stories

Vishal puts his next on hold owing to Irrfan's critical health

It's not a secret anymore that actor Irrfan Khan, who is a force to reckon with not just in Bollywood but all over the world, has been diagnosed with a rare disease called NeuroEndocrine Tumour. Reportedly, the National Award-winning actor is currently undergoing treatment in London.

We all know that before Irrfan came to know about his rare disease, he was psyched about starting his next film with acclaimed filmmaker Vishal Bhardwaj. Deepika Padukone, his co-star from the slice-of-life film Piku, was also a part of the highly anticipated movie.


However, as the movie was drawing towards its commencement date in March, Irrfan broke the news of his deteriorating health to the world and the makers had to cancel the shoot.

Vishal Bhardwaj, who is very close to Khan, has now decided to put his film on hold until the actor recovers fully from his bad health. The director took to Twitter and shared that he will begin the project once the warrior Irrfan returns as a winner.

“Irrfan is a warrior and we know he will conquer this battle. Therefore @deepikapadukone, Prernaa (Arora) @kriarj and I have decided to reschedule our film and start with renewed energy and celebration when our warrior returns as a winner," he tweeted.

The untitled film is expected to be a gangster-drama.

More For You

Netflix buyback

The company ended Q1 with $12.3 billion in cash, partly because buybacks were paused during the Warner Bros process

Getty Images

Netflix approves $25 billion buyback after scrapping Warner Bros bid

Highlights

  • Netflix board approved a $25bn share repurchase on 22 April, with no expiry date.
  • The move follows Netflix abandoning its $83bn bid for Warner Bros' streaming and studio assets.
  • Netflix stock has fallen more than 10 per cent since weak Q2 guidance, closing at $93.24 on 22 April.
Netflix has approved a $25 billion share buyback programme, using capital it had kept aside for its failed bid to buy Warner Bros.
The board gave the green light on 22 April, with the decision disclosed in an SEC filing the next day.
There is no expiry date on the programme. It comes on top of an existing December 2024 buyback that still had $6.8 billion left as of 31 March.

Earlier this year, Netflix pulled out of an $83 billion deal to acquire Warner Bros' streaming and studio assets after Paramount Skydance made a rival bid for Warner Bros. Discovery. Paramount then paid Netflix a $2.8 billion exit fee.

Co-CEOs Ted Sarandos and Greg Peters had already said the company would restart share buybacks once the deal was off.

Netflix shares have had a rough ride. They hit an all-time high of $134.12 in June 2025, then fell more than 40 per cent when the Warner Bros deal was announced.

Keep ReadingShow less